Recruiting OBSERVATIONAL NCT06940934
Post-Market Product Surveillance of Intracranial ANeurysms Treated With Commercial ReGistered ACANDIS Devices in FrancE (ANCRAGE PMS)
ANCRAGE: Post-Market Product Surveillance of Intracranial ANeurysms Treated With Commercial ReGistered ACANDIS Devices in FrancE
Sponsor: Acandis GmbH
Conditions
Intracranial Aneurysms
Updated 1 time since 2025 Last updated: Apr 16, 2025 Started: Dec 1, 2021 Primary completion: Dec 31, 2026 Completion: Apr 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06940934, this observational or N/A phase trial focuses on Intracranial Aneurysms and remains actively recruiting participants. Sponsored by Acandis GmbH, it has been updated 1 time since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Acandis GmbH
Data source: Acandis GmbH
For direct contact, visit the study record on ClinicalTrials.gov .